XML 23 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 240.7 $ 280.6
Accounts receivable, net of allowances (2024 - $1.7 million; 2023 - $2.0 million) 90.8 113.2
Inventories, net 219.8 228.0
Deferred charges and prepaid expenses 29.9 10.3
Other current assets 6.1 24.7
Total Current Assets 587.3 656.8
Property, plant and equipment, net 507.3 492.5
Operating lease right-of-use assets 11.7 11.4
Pension assets 5.5 9.9
Intangible assets, net 3.4 2.7
Other non-current assets 1.5 2.0
Total Assets 1,116.7 1,175.3
Current Liabilities    
Accounts payable 119.2 133.3
Salaries, wages and benefits 16.8 26.8
Accrued pension and postretirement costs 66.5 43.5
Current operating lease liabilities 4.8 5.0
Current convertible notes, net 5.4 13.2
Government funding liabilities 53.5 0.0
Other current liabilities 15.3 26.6
Total Current Liabilities 281.5 248.4
Non-Current Liabilities    
Credit Agreement 0.0 0.0
Non-current operating lease liabilities 6.9 6.4
Accrued pension and postretirement costs 110.2 160.5
Deferred income taxes 14.3 15.0
Other non-current liabilities 13.3 13.4
Total Liabilities 426.2 443.7
Shareholders’ Equity    
Preferred shares, without par value; authorized 10.0 million shares, none issued 0.0 0.0
Common shares, without par value; authorized 200.0 million shares; issued 2024 - 48.2 million shares; issued 2023 - 47.1 million shares 0.0 0.0
Additional paid-in capital 843.9 844.2
Retained deficit (52.4) (53.7)
Treasury shares - 2024 - 5.9 million; 2023 - 4.0 million (108.7) (71.3)
Accumulated other comprehensive income (loss) 7.7 12.4
Total Shareholders’ Equity 690.5 731.6
Total Liabilities and Shareholders’ Equity $ 1,116.7 $ 1,175.3